201 related articles for article (PubMed ID: 6852923)
1. Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.
Snippe H; van Houte AJ; van Dam JE; De Reuver MJ; Jansze M; Willers JM
Infect Immun; 1983 Jun; 40(3):856-61. PubMed ID: 6852923
[TBL] [Abstract][Full Text] [Related]
2. Nonionic block polymer surfactants modulate the humoral immune response against Streptococcus pneumoniae-derived hexasaccharide-protein conjugates.
Zigterman GJ; Schotanus K; Ernste EB; Van Dam GJ; Jansze M; Snippe H; Willers JM
Infect Immun; 1989 Sep; 57(9):2712-8. PubMed ID: 2759707
[TBL] [Abstract][Full Text] [Related]
3. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1.
McLay J; Leonard E; Petersen S; Shapiro D; Greenspan NS; Schreiber JR
J Immunol; 2002 Apr; 168(7):3437-43. PubMed ID: 11907102
[TBL] [Abstract][Full Text] [Related]
4. Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to
Kurbatova EA; Akhmatova NK; Zaytsev AE; Akhmatova EA; Egorova NB; Yastrebova NE; Sukhova EV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
Front Immunol; 2020; 11():578019. PubMed ID: 33343566
[TBL] [Abstract][Full Text] [Related]
5. Measurement of the humoral immune response against Streptococcus pneumoniae type 3 capsular polysaccharide and oligosaccharide containing antigens by ELISA and ELISPOT techniques.
Zigterman GJ; Verheul AF; Ernste EB; Rombouts RF; De Reuver MJ; Jansze M; Snippe H; Willers JM
J Immunol Methods; 1988 Jan; 106(1):101-7. PubMed ID: 3339246
[TBL] [Abstract][Full Text] [Related]
6. Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responses.
Milligan GN; Fairchild RL; Sterner KE; Braley-Mullen H
Eur J Immunol; 1990 Mar; 20(3):595-603. PubMed ID: 2318251
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice.
Peeters CC; Tenbergen-Meekes AM; Evenberg DE; Poolman JT; Zegers BJ; Rijkers GT
J Immunol; 1991 Jun; 146(12):4308-14. PubMed ID: 2040803
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic properties of octasaccharide-protein conjugates derived from Klebsiella serotype 11 capsular polysaccharide.
Zigterman JW; van Dam JE; Snippe H; Rotteveel FT; Jansze M; Willers JM; Kamerling JP; Vliegenthart JF
Infect Immun; 1985 Feb; 47(2):421-8. PubMed ID: 3881349
[TBL] [Abstract][Full Text] [Related]
9. [Immunogenic activity of a conjugate of synthetic hexasaccharide related to a streptococcus pneumoniae serotype 14 capsule polysaccharide chain fragment].
Kurbatova EA; Vorob'ev DS; Egorova NB; Semenova IB; Sukhova EV; Iashunskiĭ DV; Tsvetkov IuE; Nifant'ev NÉ
Zh Mikrobiol Epidemiol Immunobiol; 2013; (6):56-63. PubMed ID: 24605676
[TBL] [Abstract][Full Text] [Related]
10. Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide.
Alonso de Velasco E; Verheul AF; Veeneman GH; Gomes LJ; van Boom JH; Verhoef J; Snippe H
Vaccine; 1993 Nov; 11(14):1429-36. PubMed ID: 8310762
[TBL] [Abstract][Full Text] [Related]
11. Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.
Jansen WT; Hogenboom S; Thijssen MJ; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H; Verheul AF
Infect Immun; 2001 Feb; 69(2):787-93. PubMed ID: 11159969
[TBL] [Abstract][Full Text] [Related]
12. Maternal immunity and antibody response of neonatal mice to pneumococcal type 19F polysaccharide.
Lee CJ; Ching ED; Vickers JH
J Clin Microbiol; 1991 Sep; 29(9):1904-9. PubMed ID: 1774315
[TBL] [Abstract][Full Text] [Related]
13. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
Alonso de Velasco E; Verheul AF; van Steijn AM; Dekker HA; Feldman RG; Fernández IM; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H
Infect Immun; 1994 Mar; 62(3):799-808. PubMed ID: 7509318
[TBL] [Abstract][Full Text] [Related]
14. Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.
Norcross EW; Sanders ME; Moore QC; Taylor SD; Tullos NA; Caston RR; Dixon SN; Nahm MH; Burton RL; Thompson H; McDaniel LS; Marquart ME
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9232-43. PubMed ID: 22039231
[TBL] [Abstract][Full Text] [Related]
15. Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3.
Lefeber DJ; Benaissa-Trouw B; Vliegenthart JF; Kamerling JP; Jansen WT; Kraaijeveld K; Snippe H
Infect Immun; 2003 Dec; 71(12):6915-20. PubMed ID: 14638780
[TBL] [Abstract][Full Text] [Related]
16. Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.
Schneerson R; Robbins JB; Chu C; Sutton A; Vann W; Vickers JC; London WT; Curfman B; Hardegree MC; Shiloach J
Infect Immun; 1984 Sep; 45(3):582-91. PubMed ID: 6332076
[TBL] [Abstract][Full Text] [Related]
17. Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate.
Lu CH; Lee CJ; Kind P
Infect Immun; 1994 Jul; 62(7):2754-60. PubMed ID: 8005665
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates.
Beuvery EC; van Rossum F; Nagel J
Infect Immun; 1982 Jul; 37(1):15-22. PubMed ID: 6809623
[TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.
Lagergard T; Shiloach J; Robbins JB; Schneerson R
Infect Immun; 1990 Mar; 58(3):687-94. PubMed ID: 2407652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
